Ovintiv Inc.
No SEC Form 4 filings for $OVV in the last 30 days.
Simply Wall St reports Ovintiv (OVV) held a July 23 update combining Q2 2026 earnings, revised production guidance, dividend confirmation, and share buyback details. The stock fell 4.59% on the day and 5.42% over a week, but rose 8.74% over 30 days and 43.15% YTD. A fair-value narrative cites $70.95 vs $57.96 and a 75.2% discount to intrinsic value, with P/E at 18.2x.
Ovintiv Inc. shares rose 4.0% to $60.08 after its Q2 results. The company reported revenue of $3.0b, above analyst forecasts, but statutory EPS of $1.62 missed by 23%. For 2026, analysts raised revenue to $9.99b but cut EPS to $2.85, and kept the consensus price target at $72.36.
Ovintiv (OVV) says its Permian and Montney assets anchor its growth after selling Anadarko. Q2 Permian averaged 231k boe/d (78% liquids) and Montney 374k boe/d (27% liquids). Management estimates 12-15 years premium inventory in Permian and 15-20 in Montney. 2026 production guidance raised to 630-645k boe/d without raising capex ($2.25-$2.35B). Q2 non-GAAP free cash flow was $682M; it returned about 63% to shareholders.
Over the past 7 days, alphai's AI scored 1 news story mentioning OVV (Ovintiv Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent OVV coverage spans financial news, earnings and market movers.
Framing centers on whether the post-earnings pullback creates a valuation gap versus fair-value estimates, with margin-support claims from cost-efficiency initiatives.
The article centers on post-earnings estimate revisions for Ovintiv, with EPS cut offset by revenue upgrade, and an unchanged consensus price target.
Guidance upgrade with unchanged spending supports higher expected cash generation, but commodity and execution risks remain key swing factors.
Guidance lift with capital returns can support near-term cash-flow expectations, but the first-half net loss and commodity exposure keep downside risk elevated.
Analyst target increase and maintained Outperform can support near-term sentiment, but the article provides no new Ovintiv fundamentals beyond the call.
alphai scores every news story that mentions OVV with an AI model for sentiment and relevance, and aggregates insider trades from Ovintiv Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Simply Wall St reports Ovintiv (OVV) held a July 23 update combining Q2 2026 earnings, revised production guidance, dividend confirmation, and share buyback details. The stock fell 4.59% on the day and 5.42% over a week, but rose 8.74% over 30 days and 43.15% YTD. A fair-value narrative cites $70.95 vs $57.96 and a 75.2% discount to intrinsic value, with P/E at 18.2x.
6 min readOvintiv Inc. shares rose 4.0% to $60.08 after its Q2 results. The company reported revenue of $3.0b, above analyst forecasts, but statutory EPS of $1.62 missed by 23%. For 2026, analysts raised revenue to $9.99b but cut EPS to $2.85, and kept the consensus price target at $72.36.
4 min readOvintiv (OVV) says its Permian and Montney assets anchor its growth after selling Anadarko. Q2 Permian averaged 231k boe/d (78% liquids) and Montney 374k boe/d (27% liquids). Management estimates 12-15 years premium inventory in Permian and 15-20 in Montney. 2026 production guidance raised to 630-645k boe/d without raising capex ($2.25-$2.35B). Q2 non-GAAP free cash flow was $682M; it returned about 63% to shareholders.
6 min readOvintiv reported Q2 2026 revenue of US$3,013 million and net income of US$456 million, but a first-half 2026 net loss of US$174 million. The company raised 2026 production guidance to 630 to 645 MBOE/d, continued dividends, and completed a US$428.87 million share buyback. The stock rose 9.3% after the update.
4 min readRBC analyst commentary says Ovintiv’s portfolio strength and improving returns support valuation upside. According to RBC, it raised Ovintiv’s price target to $85 from $70 and kept an Outperform rating. The article also notes Ovintiv’s shares traded around $60.08 at the close.
2 min readTruist Securities raised its price target for Ovintiv Inc. (NYSE:OVV) to $73 from $66 and kept a Buy rating. The update followed Ovintiv’s Q2 2026 results, with Truist citing stronger well performance and oil and condensate production above the top end of guidance, while capex stayed in line. Truist expects free cash flow support and faster return of capital in 2H 2026.
4 min readOvintiv (OVV) reported Q2 2026 cash from operating activities of $1.6B versus $1.0B a year earlier. Capital investments were $574M (vs. $521M) and non-GAAP free cash flow was $682M. As of June 30, cash was $700M and long-term debt $3.7B. The company guided 2026 production at 630-645 MBOE/d and Q3 2026 capex at $550M-$600M.
5 min readSimply Wall St reports Ovintiv (OVV) posted Q2 revenue of US$3.01b, beat expectations, and issued updated production guidance. The article also cites a declared dividend and ongoing share buybacks. It presents a “fair value” estimate of $70.95 versus a $63.13 close, implying about 11% undervaluation, while noting shale exposure and service-cost inflation risks.
3 min readOvintiv (OVV) reported Q2 free cash flow of $682 million and cash flow per share of $4.46, with year-to-date free cash flow about $1.3 billion. Net debt fell about $3.4 billion to $2.995 billion, and Fitch upgraded its credit rating to BBB. Ovintiv raised full-year oil and condensate guidance to 210-212 kbpd and expects 3Q capex around $575 million.
6 min readAnalysts at Siebert Williams Shank & Co, UBS, and Wells Fargo reiterated Buy ratings on Ovintiv (OVV), Oneok (OKE), and Crescent Energy Class A (CRGY), citing price targets of $80, $108, and $18. TipRanks shows OVV consensus Strong Buy at $70.39, OKE Moderate Buy at $97.44, and CRGY Strong Buy at $16. Shares closed $61.39, $93.23, and $11.39, respectively.
3 min read
